Topical application of a TRPA1 antagonist reduced nociception and inflammation in a model of traumatic muscle injury in rats-Reference-Cited by-同舟云学术

Topical application of a TRPA1 antagonist reduced nociception and inflammation in a model of traumatic muscle injury in rats

Published:2023-09-27 Issue:6 Volume:31 Page:3153-3166
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Kudsi Sabrina Qader,de David Antoniazzi Caren Tatiane,Camponogara Camila,Meira Graziela Moro,de Amorim Ferreira Marcella,da Silva Ana Merian,Dalenogare Diéssica Padilha,Zaccaron Rubya,dos Santos Stein Carolina,Silveira Paulo Cesar Lock,Moresco Rafael Noal,Oliveira Sara Marchesan,Ferreira Juliano,Trevisan Gabriela^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-023-01337-3.pdf

Reference65 articles.

1. Antoniazzi CT, De Prá SD, Ferro PR et al (2018) Topical treatment with a transient receptor potential ankyrin 1 (TRPA1) antagonist reduced nociception and inflammation in a thermal lesion model in rats. Eur J Pharm Sci 125:28–38

2. Araújo DSM, Miya-Coreixas VS, Pandolfo P et al (2017) Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia. Exp Eye Res 154:116–212

3. Asgar J, Zhang Y, Saloman J et al (2015) The role of TRPA1 in muscle pain and mechanical hypersensitivity under inflammatory conditions in rats. Neuroscience 310:206–215

4. Barbieri E, Sestili P (2012) Reactive oxygen species in skeletal muscle signaling. J Sig Transduct 2012:1–17

5. Berke MS, Colding-Jørgensen P, Hestehave S et al (2022) Effects of buprenorphine on acute pain and inflammation in the adjuvant-induced monoarthritis rat model. Heliyon 8:e11554